Page 134 - Developing News Today

ROCKVILLE, Md., April 03, 2023 -- Supernus Pharmaceuticals, Inc. , a biopharmaceutical company focused on developing and commercializing products for the treatment of central nervous system ... | April 3, 2023

WALTHAM, Mass., April 03, 2023 -- Xilio Therapeutics, Inc. , a biotechnology company developing tumor-activated immuno-oncology therapies for people living with cancer, today announced... | April 3, 2023

Hello. high pressure dominates the weather over the next few days or so. it is looking dry and fine of a lot more be sky and sunshine to come to. the sunshine continues this afternoon. there will always be more cloud across scotland and northern ireland but even here, some sunny spells. here it is going to feel a little cooler. temperatures peaking between nine and i3 little cooler. temperatures peaking between nine and 13 degrees. 0vernight tonight, with clear skies and light falling wins, ther...

Abliva AB , a clinical-stage biotech company developing medicines for the treatment of rare and severe primary mitochondrial diseases, today announced that the English version of the Annual report for... | March 31, 2023

BOSTON and ATLANTA, March 31, 2023 /PRNewswire/ -- Inhibikase Therapeutics, Inc. , a clinical-stage pharmaceutical company developing protein kinase inhibitor therapeutics to modify the course of... | March 31, 2023

SAN DIEGO, March 31, 2023 -- Cidara Therapeutics, Inc. , a biotechnology company developing long-acting therapeutics designed to improve the standard of care for patients facing serious diseases,... | March 31, 2023

IMV Inc. , a clinical-stage company developing a portfolio of immune-educating therapies based on its novel DPX® platform to treat solid and hematologic cancers, today announced that on March... | March 31, 2023

AgeX Therapeutics, Inc. , a biotechnology company developing therapeutics for human aging and regeneration, reported its financial and operating results for fourth quarter and the full year ended... | March 31, 2023

DURHAM, N.C., March 31, 2023 -- NightHawk Biosciences , a fully-integrated biopharmaceutical company focused on developing first-in-class therapies to modulate the immune system, today provided... | March 31, 2023

Regulated Information Leuven, BELGIUM, Boston, MA, US – March 31, 2023 – 07.00 PM CET – Oxurion NV a biopharmaceutical company developing next generation standard of care... | March 31, 2023